Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Prospective Randomized Study of Craniospinal RT Followed by One of Two Adjuvant Chemotherapy Regimens (CCNU, CDDP, VCR OR CPM, CDDP, VCR) for Newly-Diagnosed Average Risk MedulloblastomaMEDULLOBLASTOMA

NCT00002875 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Prospective Randomized Study of Craniospinal RT Followed by One of Two Adjuvant Chemotherapy Regimens (CCNU, CDDP, VCR OR CPM, CDDP, VCR) for Newly-Diagnosed Average Risk MedulloblastomaMEDULLOBLASTOMA
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
December 31, 1996
Completion date
January 31, 2011
Enrollment
421 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, central nervous system tumors